US 11945778
C4-carbonothioate-substituted tryptamine derivatives and methods of using
granted A61KA61K31/4045A61P
Quick answer
US patent 11945778 (C4-carbonothioate-substituted tryptamine derivatives and methods of using) held by Enveric Biosciences Canada Inc. expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enveric Biosciences Canada Inc.
- Grant date
- Tue Apr 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K31/4045, A61P, A61P25/00